|
|
||||||||
Original Research |
1 Clinical Department of Radiology II, Innsbruck Medical University, Anichstr.
35, A-6020 Innsbruck, Austria.
2 Clinical Department of Cardiology, Innsbruck Medical University, Innsbruck,
Austria.
3 Clinical Department of Cardiac Surgery, Innsbruck Medical University,
Innsbruck, Austria.
Received June 7, 2005;
accepted after revision September 18, 2005.
Address correspondence to G. M. Feuchtner
(Gudrun.Feuchtner{at}uibk.ac.at).
Abstract
|
|
|---|
SUBJECTS AND METHODS. We examined 71 patients prospectively with 16-MDCT angiography using retrospective ECG gating during the mid-to-end diastolic phase. A visible central valvular leakage area was considered as a diagnostic criterion for AR. The central valvular leakage area was quantified in patients with positive transthoracic echocardiography (TTE). We compared 16-MDCT to Doppler TTE, the accepted diagnostic standard based on semiquantitative regurgitation jet analysis (grade 0-3+ for mild, moderate, and severe).
RESULTS. The overall sensitivity of 16-MDCT for the identification
of patients with AR was 81%. The specificity was 91%, the negative predictive
value was 70%, and the positive predictive value was 95%. Of the 71 patients,
48 had AR determined by TTE, and 16-MDCT correctly detected AR in 39 of those
48 patients. The sensitivity of 16-MDCT for the detection of patients with
moderate and severe AR (grade
1.5+) was 95%, and the specificity was 96%
(20 of 21 patients). The sensitivity of 16-MDCT for identification of patients
with mild AR (grade
1+) was 70%, and the specificity was 92% (19 of 27
patients). Quantification of the central valvular leakage area was not
possible in 50% of cases with AR by TTE because of valve calcifications.
CONCLUSION. Sixteen-MDCT coronary angiography provides an accurate,
noninvasive imaging technique to detect moderate and severe aortic
regurgitation (grade
1.5+). However, severe valve calcifications and mild
AR limit its results.
Keywords: aortic valve disease CT coronary angiography CT coronary arteriography heart MDCT
|
|
|---|
This study assesses the clinical accuracy of 16-MDCT in the identification of AR in patients who undergo 16-MDCT coronary angiography, based on the visibility of a central valvular leakage area, compared with the currently accepted diagnostic standard, transthoracic echocardiography (TTE).
|
|
|---|
MDCT Examination Technique
All examinations were performed using a 16-MDCT scanner (Sensation 16,
Siemens Medical Solutions) [7].
Collimation was 12 x 0.75 mm, table translation speed was 6.7 mm/sec,
gantry rotation time was 0.42 sec, tube current was 400-500 mAs, tube voltage
was 120 kV, and the effective radiation dose ranged between 6.7 and 13 mSv
[8]. A bolus of 100-mL iodine
contrast agent (iodixanol, Visipaque 320, Amersham Health) was injected IV
into an antecubital vein at a flow rate of 3 to 4 mL/sec using a power
injector (Ulrich Medizintechnik). Scan delay was calculated by measuring CT
attenuation values at the ascending aorta using dedicated software (DynEva,
Siemens Medical Solutions), after injecting a 20-mL test bolus of contrast
agent. The time point of the highest CT attenuation was taken as the scan
delay. Scanning was performed during a single inspiratory breath-hold of 20 to
28 sec. A ß-blocker was injected IV (1-5 mg metoprolol tartrate, Beloc,
Schering) before the examination if the heart rate was greater than 75 beats
per minute (bpm).
|
|
|
|
|
|
|
|
|
|
|
Transthoracic Echocardiography
All measurements were performed using a standard sonography system (Sequoia
256, Acuson-Siemens) equipped with a 3.5/1.75 MHz transducer. Aortic valve
regurgitation was assessed semiquantitatively by calculation of jet area/jet
length, proximal jet width, and the pressure half-time method
[7]. The severity of AR was
classified as grade 0-3+ (mild, moderate, severe)
[9]. Mean and maximum
transvalvular pressure gradients were measured to assess whether aortic valve
stenosis was present.
Statistical Analysis
Statistical analysis was performed using SPSS software (V8.0, SPSS). The
sensitivity, specificity, negative predictive value (NPV), and positive
predictive value (PPV) of 16-MDCT for identifying patients with AR were
calculated. Interrater agreement was calculated by using weighted Cohen's
kappa value. An unpaired Student's t test was used to determine the
significance of differences in aortic valve calcification scores. The
correlation between the severities of AR as measured by 16-MDCT and by TTE was
determined by Spearman's rank correlation coefficient.
|
|
|---|
The severity of AR was classified as moderate or severe (grade
1.5+)
in 21 patients and as mild (grade
1.0+) in 27 patients with TTE. Twenty
of the 21 patients who had AR of grade
1.5+ were detected with 16-MDCT
(sensitivity 95% [95% CI, 77-99], specificity 96% [95% CI, 86-98], PPV 90%
[95% CI, 72-97], and NPV 97% [95% CI, 89-99]). Sixteen-MDCT identified 19 of
27 patients who had mild AR grade
1+ as determined by TTE (sensitivity
70% [95% CI, 51-84], specificity 92% [95% CI, 75-97]). Interrater agreement
was 0.96 ± 0.12 (weighted kappa value). Two patients were
false-positive on 16-MDCT examination; both had valve calcifications.
Quantification of the central valvular leakage area (aortic regurgitation area [ARA]) by 16-MDCT was performed in 24 (50%) of the 48 patients. The mean ARA was 0.41 cm2 ± 0.47 (Table 1). In the remaining patients, quantification of ARA was not performed. In the opinion of both observers, circling ARA was judged as "probably inaccurate" because valve calcifications located at leaflets margins caused artifacts that projected into the ARA. The ARA as measured by 16-MDCT was correlated with the graduation of AR severity (grade 0-3+) by TTE (r = 0.95, p < 0.001, Spearman's rank correlation).
|
A significant difference in aortic valve Agatston calcium score (ACS) (p = 0.004, unpaired Student's t test) was noted between the patients in whom quantification of ARA was possible and not possible (ACS: 1655.9 ± 1672 vs 3796.9 ± 2684).
The mean heart rate in our study population was 64 bpm ± 12.6 (minimum 44 bpm, maximum 78 bpm). Six patients had a right ventricular pacemaker; the other patients were in sinus rhythm.
|
|
|---|
1.5+) in patients undergoing 16-MDCT coronary
angiography, irrespective of the extent of valve calcifications. In contrast,
the technique was less sensitive in detecting patients with mild AR (grade
1.0+), which might be explained by the fact that the spatial resolution
of TTE is still superior to 16-MDCT. Furthermore, TTE is a technically
different approach, based on Doppler flow analysis. However, the new 64-MDCT
scanners provide higher spatial resolution than 16-MDCT and therefore improve
aortic valve imaging. In addition, dedicated 4D cardiac postprocessing
software is now available for 64-MDCT cardiac systems, facilitating the
assessment of aortic valve dynamics during the cardiac cycle. The aortic valve
is usually closed during diastole. Our data show in the presence of AR,
16-MDCT can detect a central valvular leakage area because the aortic valve
leaflets do not close up tightly during diastole. This aortic valve
regurgitation area could be quantified in 50% of our patients. However,
quantification of ARA was evaluated as "probably inaccurate" and
therefore was not performed in the remaining patients because of the presence
of severe valve calcifications located at cusp margins, which caused blurring,
and partial volume or beam-hardening artifacts that projected into the
ARA.
Clinical Applications
Concomitant AR is frequently present in patients with ascending aortic
aneurysm or degenerative aortic valve stenosis. Degenerative aortic stenosis
is the second most common cardiovascular disease with a prevalence of 2-7% in
Western European and North American people who are older than 65 years
[10]. Coronary artery disease
comorbidity in patients with degenerative aortic stenosis is relatively high
because the pathomechanisms involved are similar and because coronary risk
factors influence the progression of aortic stenosis
[11,
12]. Therefore, radiologists
and cardiologists interpreting coronary and ascending aortic 16-MDCT
angiograms should evaluate the aortic valve simultaneously for concomitant
AR.
Also, AR may develop secondarily either to rheumatic fever or to endocarditis, or may be congenital in patients with bicuspid valves. These patients may be young and may have a low pretest probability of coronary artery disease. Patients with severe AR require surgical treatment [10] and preoperative evaluation of coronary artery disease, which is currently routinely performed with cardiac catherization. Accordingly, these patients would be a target group for replacement of cardiac catheterization with 16- and 64-MDCT coronary angiography. However, better evaluation of the diagnostic performance of 16- and 64-MDCT coronary angiography for use with potential valve surgery patients can be done when results of ongoing clinical trials become available.
In contrast to cardiac catheterization, MDCT allows a detailed visualization of aortic valve morphology [13]. For example, the extent and localization of valve calcifications can be displayed, and differentiation between tricuspid and bicuspid valve shapes is feasible (Fig. 1A, 1B), which may provide interesting information that will help the cardiac surgeon select the surgical approach. Differentiation between bicuspid and tricuspid valve morphology may be difficult with TTE. Also, 16-MDCT allows detection of severe aortic regurgitation in a patient with acute ascending aortic dissection, which is important information to have before performing emergency surgical repair [14], supporting the use of 16- and 64-MDCT in patients with acute chest pain.
In conclusion, 16-MDCT provides a noninvasive, reliable imaging technique
to identify moderate and severe aortic regurgitation of grade
1.5+ in
patients undergoing 16-MDCT coronary angiography. Both 16- and 64-MDCT might
also allow a new noninvasive, preoperative diagnostic approach in patients
with planned cardiac surgery in the future.
|
|
|---|
This article has been cited by other articles:
![]() |
G. M. Feuchtner, W. Dichtl, S. Muller, D. Jodocy, T. Schachner, A. Klauser, and J. O. Bonatti 64-MDCT for Diagnosis of Aortic Regurgitation in Patients Referred to CT Coronary Angiography Am. J. Roentgenol., July 1, 2008; 191(1): W1 - W7. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ryan, S. Abbara, R. R. Colen, S. Arnous, M. Quinn, R. C. Cury, and J. D. Dodd Cardiac Valve Disease: Spectrum of Findings on Cardiac 64-MDCT Am. J. Roentgenol., May 1, 2008; 190(5): W294 - W303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schroeder, S. Achenbach, F. Bengel, C. Burgstahler, F. Cademartiri, P. de Feyter, R. George, P. Kaufmann, A. F. Kopp, J. Knuuti, et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: Report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology Eur. Heart J., February 2, 2008; 29(4): 531 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Tops, S. C. Krishnan, J. D. Schuijf, M. J. Schalij, and J. J. Bax Noncoronary Applications of Cardiac Multidetector Row Computed Tomography J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 94 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stolzmann, H. Scheffel, D. Bettex, C. Karlo, T. Frauenfelder, R. Pretre, B. Marincek, and H. Alkadhi Subvalvular aortic stenosis: Comprehensive cardiac evaluation with dual-source computed tomography J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 240 - 241. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |